Maverick Capital

Founded in 1993, Maverick Capital is a global investment firm with offices across New York, San Francisco, London, Hong Kong, Philadelphia, and Dallas. The firm primarily manages private investment funds for qualified investors, focusing on long/short hedged equity strategies to grow and preserve capital. Since its inception, Maverick has strategically invested in private companies with disruptive business models or technologies, actively partnering with portfolio teams to build businesses.

Suzanne Guthrie

CFO

Andrew Homan

Managing Director

Jéssica Leão

Principal

Prateesh Maheshwari

Managing Director

Soren Sudhof

Managing Director

215 past transactions

Nourish

Series B in 2025
Nourish improves people's health by facilitating easy access to clinical-grade nutrition care via its telehealth platform. It connects users with registered dietitians for personalized assessments, treatment plans, ongoing support, and insurance coverage.

Chapter

Series D in 2025
Chapter is a company that specializes in Medicare advisory services aimed at helping seniors navigate their health coverage options. By offering a comprehensive Medicare navigation platform, Chapter assists retirees in making informed decisions regarding their health insurance, ensuring they select coverage that best suits their individual needs while minimizing costs. The platform fosters transparency by aligning the interests of Medicare advisors and consumers, enabling independent recommendations that consider a wide range of options. In addition to health coverage support, Chapter provides retirees with tailored resources such as coupons, tax advice, and technology tips, all designed to enhance their quality of life and security as they age.

Daymark Health

Seed Round in 2025
Daymark Health is a healthcare company specializing in supportive care services for cancer patients. It connects primary care physicians, oncologists, and care teams to provide virtual and home-based care, symptom management, care navigation, social support, and mental health services. These services are delivered by nurse practitioners, social workers, and health partners, ensuring comprehensive, personalized care that addresses both medical and non-medical needs throughout the patient's treatment journey.

AheadComputing

Seed Round in 2025
AheadComputing is a technology company that designs and licenses high-performance microprocessor cores, along with related support services. Their focus is on RISC-V core intellectual property, offering scalable solutions for next-generation embedded systems. By providing efficient and scalable embedded systems, AheadComputing helps clients enhance performance, reduce power consumption, and accelerate time-to-market for their devices across diverse applications.

Aligned Marketplace

Seed Round in 2025
Aligned Marketplace is a national healthcare provider that offers personalized, advanced primary care services to employees of self-insured companies. It operates a network of local offices and virtual care options, delivering proactive, coordinated care through a value-based model. This includes same-day/next-day appointments and complete access to primary care services, all administered through a single, shared savings arrangement with employers.

Esperto Medical

Series A in 2024
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostics for both hospital and remote patient monitoring. The company utilizes innovative resonance sonomanometry technology, which employs acoustic stimulation to provide continuous and noninvasive blood pressure measurements without the need for calibration. By enabling round-the-clock monitoring of vital signs, Esperto Medical’s devices aim to enhance accessibility to medical care through automation, allowing patients to effectively manage their health from home or within clinical settings.

Terray Therapeutics

Series B in 2024
Founded in 2018, Terray Therapeutics is a biotechnology company based in Pasadena, California. It integrates experimentation and computation to enhance small molecule drug discovery, focusing on intractable diseases. The company's platform generates precise data through a rapid design-make-test-analyze cycle, enabling efficient exploration of chemical space.

TensorWave

Venture Round in 2024
TensorWave specializes in providing advanced AI and high-performance computing (HPC) cloud infrastructure. It offers scalable, memory-optimized technology powered by AMD Instinct GPUs, ensuring high performance and energy efficiency for demanding AI and machine learning workloads. The company's services include direct liquid cooling, high-speed network storage, and seamless integration capabilities, enabling enterprises to effectively harness the power of artificial intelligence.

Orasis Pharmaceuticals

Series D in 2024
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.

Spear Bio

Series A in 2024
Spear Bio is a biotechnology company based in Weston, Massachusetts, founded in 2021. The company specializes in ultrasensitive protein detection technology, which significantly enhances healthcare diagnostics. Its innovative approach enables the quantification of minute protein biomarkers from samples collected at home, facilitating self-testing and telemedicine applications. By allowing clinicians to detect these biomarkers from small sample volumes, Spear Bio's technology integrates seamlessly into existing workflows for sample collection, processing, and detection, thereby improving the overall efficiency of healthcare delivery.

Daffodil Health

Seed Round in 2024
Daffodil Health is a pediatric behavioral health platform focused on providing support for special needs children and their families. The company offers a comprehensive platform that guides parents navigating the complexities of their neurodiverse child's development. Through an initial questionnaire designed for parents who observe developmental challenges in their children, Daffodil Health facilitates a free online consultation to discuss the responses and identify suitable therapeutic programs. This approach empowers parents to take an active role in managing their child's behavioral health journey, utilizing multi-modal therapies and real-time support tailored to their specific needs.

Chapter

Series C in 2024
Chapter is a company that specializes in Medicare advisory services aimed at helping seniors navigate their health coverage options. By offering a comprehensive Medicare navigation platform, Chapter assists retirees in making informed decisions regarding their health insurance, ensuring they select coverage that best suits their individual needs while minimizing costs. The platform fosters transparency by aligning the interests of Medicare advisors and consumers, enabling independent recommendations that consider a wide range of options. In addition to health coverage support, Chapter provides retirees with tailored resources such as coupons, tax advice, and technology tips, all designed to enhance their quality of life and security as they age.

Thintronics

Series A in 2024
Thintronics is a consumer electronics company specializing in materials science. It develops a platform that enhances data transfer speeds and reduces energy consumption in electronic devices. This is achieved through innovative thin-film materials, benefiting industries like artificial intelligence, data centers, and radio frequency systems.

Clarity Pediatrics

Seed Round in 2024
Clarity Pediatrics is a healthcare company focused on transforming pediatric chronic care, specifically for children diagnosed with ADHD. With nearly 10% of American children affected by this condition, the company aims to alleviate the challenges parents face in accessing appropriate care. Clarity Pediatrics has developed a virtual pediatric ADHD clinic that leverages a tech-enabled clinical model, offering features such as video conferencing, secure messaging, and electronic health records. This innovative approach is designed to deliver high-quality, evidence-based care to families, regardless of their location or insurance status. Through its platform, Clarity Pediatrics strives to achieve exceptional health outcomes that can significantly improve the developmental trajectory of affected children.

Auradine

Series B in 2024
Auradine specializes in web infrastructure solutions for blockchain, security, and privacy. It offers software, hardware, and cloud services designed for scalability, sustainability, and security.

SiMa.ai

Series C in 2024
SiMa.ai is a software-centric, embedded edge machine learning system-on-chip company that develops a complete MLSoC platform combining hardware and software to enable high-performance, low-power machine learning inference on embedded edge devices. The platform supports traditional computing with ML inference, delivers push-button deployment and scaling at the edge, and adapts to various frameworks, networks, models, sensors, and modalities. It targets applications from computer vision to generative AI, offering improvements in performance and energy efficiency while enabling easy integration and secure operation for edge deployments.

Aligned Marketplace

Seed Round in 2024
Aligned Marketplace is a national healthcare provider that offers personalized, advanced primary care services to employees of self-insured companies. It operates a network of local offices and virtual care options, delivering proactive, coordinated care through a value-based model. This includes same-day/next-day appointments and complete access to primary care services, all administered through a single, shared savings arrangement with employers.

Nourish

Series A in 2024
Nourish improves people's health by facilitating easy access to clinical-grade nutrition care via its telehealth platform. It connects users with registered dietitians for personalized assessments, treatment plans, ongoing support, and insurance coverage.

BlueFlag Security

Seed Round in 2024
BlueFlag Security is a comprehensive security services provider, safeguarding businesses and individuals through a multi-layered defense platform. This platform integrates identity security, open-source software risk management, and developer tool posture management, offering robust protection against evolving cyber threats.

Oula Health

Series B in 2024
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Areteia Therapeutics

Series A in 2024
Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.

Silicon Box

Series B in 2024
Silicon Box specializes in advanced semiconductor packaging services. It offers full execution capabilities from initial design to final manufacturing of standard single chip packages, as well as sophisticated chiplet-based systems. The company's expertise enables applications such as AI, HPC, EV, automotive, power management, mobile chipsets, and more.

Devoted Health

Series E in 2023
Founded in 2017, Devoted Health is dedicated to enhancing the health and well-being of older Americans by offering integrated Medicare Advantage plans. They provide personalized care through a combination of local providers, virtual and in-home care, dedicated guides, and advanced technology.

Spear Bio

Seed Round in 2023
Spear Bio is a biotechnology company based in Weston, Massachusetts, founded in 2021. The company specializes in ultrasensitive protein detection technology, which significantly enhances healthcare diagnostics. Its innovative approach enables the quantification of minute protein biomarkers from samples collected at home, facilitating self-testing and telemedicine applications. By allowing clinicians to detect these biomarkers from small sample volumes, Spear Bio's technology integrates seamlessly into existing workflows for sample collection, processing, and detection, thereby improving the overall efficiency of healthcare delivery.

Tenstorrent

Venture Round in 2023
Tenstorrent Inc. is a technology company based in Toronto, Canada, with an additional office in Austin, Texas, founded in 2016. The company specializes in the development and manufacturing of application-specific integrated circuits (ASICs) tailored for machine learning and data processing tasks. Its hardware architecture is designed to support a range of applications, from battery-powered Internet of Things (IoT) devices to large-scale cloud servers, providing scalable solutions for deep learning. Tenstorrent's offerings enable developers and researchers in the artificial intelligence sector to enhance computational performance and adapt algorithms effectively, positioning the company as a key player in advancing AI technology.

Gather Health

Series A in 2023
Gather Health is an international healthcare technology company dedicated to empowering chronic disease patients to enhance their health. The company develops mobile and cloud-based healthcare applications that utilize cutting-edge medical and behavioral research to motivate and educate patients. By connecting physicians, patients, their families, and communities, Gather Health aims to provide continuous and holistic care that leads to improved health outcomes. The rise in chronic diseases such as obesity, diabetes, and hypertension has created a pressing need for effective patient care solutions, especially given the shortage of healthcare providers. Gather Health's flagship product, the Gather Health Diabetes platform, is currently utilized by physicians and patients in various cities across Hong Kong and India, including Mumbai and Bangalore, demonstrating positive health outcomes for users. Headquartered in Hong Kong, with additional offices in Beijing, New York, and India, the company boasts a diverse team of clinicians, health experts, interaction designers, and engineers experienced in the global healthcare landscape.

Zus Health

Series A in 2023
Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.

Oops

Seed Round in 2022
Oops is a venture-backed startup founded in 2022 and based in Salt Lake City, Utah. The company provides an online platform that simplifies the process of returning products by offering doorstep services for packing, taping, labeling, and transporting items. By streamlining returns, Oops enables individuals to manage their returns conveniently from home, saving them time, effort, and resources.

Infleqtion

Series B in 2022
Infleqtion, with offices in the United States, United Kingdom, and Australia, specializes in delivering advanced quantum information solutions tailored to meet critical market needs. Building on 17 years of pioneering research from ColdQuanta, the company develops software-configured, quantum-enabled products that enhance precision and processing power for applications in positioning, navigation, timing, global communication security, and efficiency. Infleqtion's technology serves various sectors, including commercial enterprises and governmental organizations, by providing high-value information streams that facilitate innovation in quantum matter. Its offerings encompass hardware products and AI-powered solutions aimed at advancing resilience in energy distribution and accelerating developments in quantum computing.

CareHarmony

Series A in 2022
Founded in 2015, CareHarmony specializes in whole-person care coordination services. It offers a Chronic Care Management solution designed to facilitate healthcare providers' transition into value-based care models while minimizing risk.

Carta Healthcare

Series B in 2022
Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

Areteia Therapeutics

Series A in 2022
Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.

Proximie

Series C in 2022
Proximie is a health technology company that enables surgeons worldwide to collaborate remotely using augmented reality, artificial intelligence, and machine learning. Its platform allows surgeons to visually guide complex surgeries, democratizing access to advanced surgical knowledge.

Coherent

Series B in 2022
Coherent is a technology company that specializes in providing software solutions for the insurance industry. Founded in 2018 and headquartered in Causeway Bay, Hong Kong, with additional offices in Shanghai, Singapore, and Manila, Coherent develops applications that enhance product development, sales, and customer engagement for insurance companies. Its flagship offerings include Factory, a tool enabling insurers to digitize backend operations and manage pricing models through Excel; Coherent Connect, a social media marketing campaign manager; Coherent Explainer, which simplifies the quote breakdown process; and Coherent Flow, designed for remote policy sales through features like video chat and electronic signatures. Additionally, the company offers Coherent Spark, a no-code platform that transforms spreadsheet-based business logic into customized APIs, facilitating better integration of software solutions across business operations.

D-ID

Series B in 2022
Founded in 2016, D-ID specializes in AI-driven video content creation. Its platform uses artificial intelligence to generate dynamic videos from images, text, and audio, enabling businesses to produce scalable, personalized narratives cost-effectively without traditional video production teams.

PrognomiQ

Venture Round in 2022
PrognomiQ is a technology company focused on transforming early disease detection and treatment through multi-omics data. It generates proteomic, genomic, and metabolomic data to provide insights into complex diseases and to improve patient outcomes. The company develops advanced test products that apply multi-omics data to detect cancers and other conditions earlier, complementing traditional diagnostics and supporting monitoring of disease recurrence. By integrating proteomic data with broader health data, PrognomiQ aims to enable clinicians to diagnose more accurately and tailor interventions, ultimately advancing preventive and precision medicine.

Volta Labs

Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in engineering and developing innovative tools for biological automation, focusing on scalable automation solutions for genetic engineering. Its platform is designed to revolutionize genomics research by providing affordable genomic sample preparation and automation for complex biological workflows. By integrating expertise from engineering, surface chemistry, and molecular biology, Volta Labs aims to streamline sample processing and enhance the capabilities of biotech organizations in the next generation of genomic automation.

FitOn

Series C in 2022
FitOn is a Los Angeles-based fitness technology company that operates a mobile application delivering live and on-demand workouts across yoga, Pilates, prenatal and postnatal programs, interval training, cardio, dance, and barre. The app supports equipment-free workouts, calorie tracking, progress monitoring, and sharing of statistics and photos, with social features such as inviting friends and a live leaderboard. FitOn serves individual users and enterprises through FitOn Health, which partners with more than 13,000 employers and major health plans to provide programs for managing chronic conditions. Since its inception, FitOn has grown to more than 12 million members who have logged over 1 billion workout minutes, reflecting broad adoption and engagement.

Lusix

Private Equity Round in 2022
Lusix specializes in cultivating lab-grown diamonds for both gemstone markets and diverse industrial applications. Utilizing proprietary technology and scientific expertise, Lusix produces high-quality diamonds with exceptional color, aiming to provide affordable luxury options that align with environmentally conscious consumers.

Dewpoint Therapeutics

Series C in 2022
Founded in 2018 and headquartered in Boston, Massachusetts, Dewpoint Therapeutics is a biotechnology company dedicated to researching biomolecular condensates and cellular function. The company aims to develop innovative treatments for various diseases such as cancer, neurodegenerative disorders, immunology, cardiovascular conditions, women's health, and virology.

Clari

Series F in 2022
Clari Inc. is a revenue operations platform based in Sunnyvale, California, founded in 2012. The company utilizes automation and artificial intelligence to consolidate and analyze activity data from various business systems, such as CRM, email, calendar, and marketing automation. This integration provides sales professionals with improved visibility into their deals and relationships, enabling them to close deals more efficiently and reduce manual reporting efforts. Clari's platform offers features like Activity Analytics, which delivers predictive insights and real-time data analysis, allowing sales teams and managers to optimize their strategies, enhance coaching, and effectively allocate resources. By streamlining revenue operations, Clari assists B2B companies, including notable clients like Qualtrics and Adobe, in forecasting business performance, managing pipelines, and minimizing customer churn.

Chapter

Series B in 2022
Chapter is a company that specializes in Medicare advisory services aimed at helping seniors navigate their health coverage options. By offering a comprehensive Medicare navigation platform, Chapter assists retirees in making informed decisions regarding their health insurance, ensuring they select coverage that best suits their individual needs while minimizing costs. The platform fosters transparency by aligning the interests of Medicare advisors and consumers, enabling independent recommendations that consider a wide range of options. In addition to health coverage support, Chapter provides retirees with tailored resources such as coupons, tax advice, and technology tips, all designed to enhance their quality of life and security as they age.

Belong Health

Series A in 2021
Belong Health collaborates with local health plans to deliver regionally tailored, personalized care to a growing community of individuals eligible for Medicare Advantage and dual-eligible special needs plans.

Heap

Series D in 2021
Heap Inc. is a company that develops an analytics infrastructure designed for online businesses, enabling them to capture and analyze customer interactions across web, mobile, and cloud platforms. Founded in 2012 and headquartered in San Francisco, California, Heap's solution automates the collection and organization of customer behavioral data, such as clicks, transactions, and form submissions, without requiring additional coding. This streamlined approach allows businesses to gain a comprehensive understanding of their users, facilitating informed decision-making and enhancing product development. Heap serves a diverse range of industries, including e-commerce, financial services, and SaaS, with over 6,000 clients that include notable companies across various sectors. The company is committed to empowering organizations to focus on insights and actions that drive business success.

Conveyor

Seed Round in 2021
Conveyor is a leading generative AI-powered platform that automates and scales customer security reviews, trusted by top SaaS companies. It reduces time spent on sharing security information and answering questionnaires by over 90%.

FitOn

Series B in 2021
FitOn is a Los Angeles-based fitness technology company that operates a mobile application delivering live and on-demand workouts across yoga, Pilates, prenatal and postnatal programs, interval training, cardio, dance, and barre. The app supports equipment-free workouts, calorie tracking, progress monitoring, and sharing of statistics and photos, with social features such as inviting friends and a live leaderboard. FitOn serves individual users and enterprises through FitOn Health, which partners with more than 13,000 employers and major health plans to provide programs for managing chronic conditions. Since its inception, FitOn has grown to more than 12 million members who have logged over 1 billion workout minutes, reflecting broad adoption and engagement.

Devoted Health

Series D in 2021
Founded in 2017, Devoted Health is dedicated to enhancing the health and well-being of older Americans by offering integrated Medicare Advantage plans. They provide personalized care through a combination of local providers, virtual and in-home care, dedicated guides, and advanced technology.

Centivo

Venture Round in 2021
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.

Chapter

Series A in 2021
Chapter is a company that specializes in Medicare advisory services aimed at helping seniors navigate their health coverage options. By offering a comprehensive Medicare navigation platform, Chapter assists retirees in making informed decisions regarding their health insurance, ensuring they select coverage that best suits their individual needs while minimizing costs. The platform fosters transparency by aligning the interests of Medicare advisors and consumers, enabling independent recommendations that consider a wide range of options. In addition to health coverage support, Chapter provides retirees with tailored resources such as coupons, tax advice, and technology tips, all designed to enhance their quality of life and security as they age.

Apna

Series C in 2021
Founded in 2019, Apna is India's largest professional networking platform dedicated to helping the country's workforce unlock unique networking and skilling opportunities. With over 35 million users across 75 cities and more than two million employers on its platform, Apna connects job seekers with relevant opportunities while enabling employers to hire talent cost-effectively.

House Rx

Seed Round in 2021
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

CCC Intelligent Solutions

Post in 2021
CCC Intelligent Solutions is a cloud‑based software provider that delivers a SaaS platform for the property and casualty insurance sector. Its technology connects more than 30,000 insurers, repair shops, automakers, parts suppliers, lenders and other partners, digitizing critical workflows, commerce and customer interactions. The platform incorporates AI, IoT, telematics and hyperscale capabilities to streamline operations and enable data‑driven decision making. CCC operates primarily in the United States and China, generating revenue through software subscriptions and related professional services.

Zus Health

Series A in 2021
Zus Health is a healthcare technology company founded in 2020 by Jonathan Bush, based in Watertown, Massachusetts. It specializes in developing a healthcare data platform that accelerates the creation of digital health solutions. The platform uniquely integrates health and non-health information, allowing healthcare professionals to gain a comprehensive understanding of patients while sharing clinical and non-clinical data without requiring the same applications. By removing traditional barriers, Zus Health empowers a new generation of healthcare builders to design technologies and services that are more affordable and customizable, aiming to enhance the overall healthcare experience.

Fractyl Health

Series F in 2021
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

Belong Health

Seed Round in 2021
Belong Health collaborates with local health plans to deliver regionally tailored, personalized care to a growing community of individuals eligible for Medicare Advantage and dual-eligible special needs plans.

CareMax

Post in 2021
CareMax is a technology-enabled care platform focused on delivering value-based care and chronic disease management for seniors. The company operates a network of medical centers that provide a wide range of healthcare and social services. Additionally, CareMax has developed a proprietary software and services platform that offers data, analytics, and rules-based decision tools to assist physicians in their practice. This integrated approach aims to enhance the quality of care for seniors while managing their healthcare needs effectively across the United States.

Cano Health

Post in 2021
Cano Health operates primary care centers across Florida, Texas, Nevada, and Puerto Rico, specializing in value-based care for seniors. Its population health management programs include wellness activities, pharmacy services, home visits, telehealth, transition of care, and high-risk/complex care management.

QuintoAndar

Series E in 2021
QuintoAndar is a Brazilian digital platform that facilitates long-term residential rentals. It connects landlords with renters, streamlining the process through its marketplace which offers rental listings, visit scheduling, and paperless transactions. The platform also provides rental insurance and handles recurring payments without requiring guarantors.

Mon Ami

Seed Round in 2021
Mon Ami is a platform-based company that serves both individuals and care providers for seniors. Its consumer-facing application connects college students with seniors and families to arrange companionship and support for conditions including dementia, Alzheimer’s, Parkinson’s, autism, and cancer. The company also offers a HIPAA-compliant software platform for aging and disability service providers that digitizes care delivery, streamlines operations, increases care capacity, and enables reporting on senior well-being. By partnering with agencies nationwide, Mon Ami aims to digitize frontline care and improve outcomes through a single integrated platform. The company was founded in 2018 and is based in Palo Alto, California, with operations across California.

SnapDocs

Series D in 2021
SnapDocs, Inc. is a real estate technology company that specializes in digital mortgage closings. Founded in 2013 and headquartered in San Francisco, California, SnapDocs provides a platform that connects lenders, title companies, notary signing agents, and homebuyers, facilitating a streamlined closing process. The platform automates interactions among these participants, ensuring efficiency, accuracy, and consumer satisfaction. It offers features such as performance metrics for mobile notary signing agents, customizable workflows for lenders and real estate professionals, and early access to closing packages for homebuyers. By leveraging advanced automation and patented technology, SnapDocs enhances the closing experience, enabling clients to save time and reduce costs while maintaining compliance. The company's focus on improving both borrower experience and business outcomes positions it as a leading solution in the mortgage closing industry.

Infleqtion

Convertible Note in 2021
Infleqtion, with offices in the United States, United Kingdom, and Australia, specializes in delivering advanced quantum information solutions tailored to meet critical market needs. Building on 17 years of pioneering research from ColdQuanta, the company develops software-configured, quantum-enabled products that enhance precision and processing power for applications in positioning, navigation, timing, global communication security, and efficiency. Infleqtion's technology serves various sectors, including commercial enterprises and governmental organizations, by providing high-value information streams that facilitate innovation in quantum matter. Its offerings encompass hardware products and AI-powered solutions aimed at advancing resilience in energy distribution and accelerating developments in quantum computing.

Collective Health

Series F in 2021
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Proximie

Series B in 2021
Proximie is a health technology company that enables surgeons worldwide to collaborate remotely using augmented reality, artificial intelligence, and machine learning. Its platform allows surgeons to visually guide complex surgeries, democratizing access to advanced surgical knowledge.

Carta Healthcare

Series A in 2021
Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

KUDO

Series A in 2021
KUDO, Inc., also known as Kudo Technologies, is a New York-based company that provides a language as a service (LaaS) platform designed for multilingual online meetings. Founded in 2016, KUDO offers a cloud-based software as a service (SaaS) solution that includes video conferencing tools with integrated support for translators and multiple audio streams. The platform facilitates multilingual live events and web conferencing, allowing businesses to communicate effectively with global audiences in their preferred languages. KUDO's innovative approach enables participants and interpreters to connect from anywhere in the world using standard computers or smartphones, making it a cost-effective option for reaching diverse markets.

Cityblock

Series C in 2021
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Cylera

Series A in 2021
Cylera is a healthcare IoT cybersecurity company that protects healthcare organizations from cyber threats and malware by providing a unified, asset-centric platform for managing devices, assessing risks, and detecting threats across the connected IoT environment. Founded in 2017 and based in New York, the company delivers centralized software that identifies all devices, analyzes vulnerabilities, and enables automated threat responses, supporting healthcare providers, enterprises, and government agencies in securing critical medical and operational IoT assets.

Caribou Biosciences

Series C in 2021
Caribou Biosciences develops cellular engineering solutions based on CRISPR technologies, offering a gene editing platform with applications in human therapeutics, disease modeling, genomics research, and agricultural biotechnology.

Garner Health

Series A in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.

Cityblock

Series C in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Centivo

Series B in 2020
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.

Infleqtion

Series A in 2020
Infleqtion, with offices in the United States, United Kingdom, and Australia, specializes in delivering advanced quantum information solutions tailored to meet critical market needs. Building on 17 years of pioneering research from ColdQuanta, the company develops software-configured, quantum-enabled products that enhance precision and processing power for applications in positioning, navigation, timing, global communication security, and efficiency. Infleqtion's technology serves various sectors, including commercial enterprises and governmental organizations, by providing high-value information streams that facilitate innovation in quantum matter. Its offerings encompass hardware products and AI-powered solutions aimed at advancing resilience in energy distribution and accelerating developments in quantum computing.

Dewpoint Therapeutics

Series B in 2020
Founded in 2018 and headquartered in Boston, Massachusetts, Dewpoint Therapeutics is a biotechnology company dedicated to researching biomolecular condensates and cellular function. The company aims to develop innovative treatments for various diseases such as cancer, neurodegenerative disorders, immunology, cardiovascular conditions, women's health, and virology.

Galecto

Series D in 2020
Galecto is a clinical-stage biotechnology company developing small molecule therapeutics targeting galectin-3 and lysyl oxidase-like 2 for treating severe diseases like fibrosis and cancer. Its lead product candidate, GB0139, is an inhaled inhibitor of galectin-3 for treating severe fibrotic lung diseases such as idiopathic pulmonary fibrosis.

PrognomiQ

Venture Round in 2020
PrognomiQ is a technology company focused on transforming early disease detection and treatment through multi-omics data. It generates proteomic, genomic, and metabolomic data to provide insights into complex diseases and to improve patient outcomes. The company develops advanced test products that apply multi-omics data to detect cancers and other conditions earlier, complementing traditional diagnostics and supporting monitoring of disease recurrence. By integrating proteomic data with broader health data, PrognomiQ aims to enable clinicians to diagnose more accurately and tailor interventions, ultimately advancing preventive and precision medicine.

Orasis Pharmaceuticals

Series C in 2020
Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.

Decent

Series A in 2020
Decent Inc. is a health insurance provider based in Mill Valley, California, that focuses on offering affordable medical insurance plans tailored for self-employed professionals. Founded in 2018, the company aims to improve healthcare access by aligning incentives to enhance health outcomes and reduce costs. One of its key offerings is the Trailblazer Plan, a comprehensive health plan designed specifically for freelancers. By prioritizing the needs of its members, Decent seeks to create a more effective and personalized healthcare experience.

Octopai

Series A in 2020
Octopai is an automated data intelligence platform that assists data teams in managing complex data environments. It provides multilayered data lineage, data discovery, and a data catalog, allowing organizations to trace their data assets and understand the flow of information within their systems. By offering a cross-platform solution that requires minimal intervention and no coding, Octopai helps businesses streamline their data operations, reduce chaos, and enhance trust in their data resources.

Seer

Series D in 2020
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.

Cityblock

Series B in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Behalf

Series D in 2020
Behalf, Inc. is a financing provider based in New York, established in 2011, with an additional office in Tel Aviv, Israel. The company specializes in facilitating commerce between business-to-business merchants and their customers by offering automated payment solutions, including instant credit and flexible payment terms at the point of sale. Behalf integrates seamlessly into merchants' sales and invoicing processes or online checkout systems, allowing business customers to access financing regardless of the invoice or transaction size. By paying merchants upfront, Behalf enhances their sales and cash flow, while also enabling small businesses to manage their operational efficiency through short-term financing and flexible repayment options.

D-ID

Series A in 2020
Founded in 2016, D-ID specializes in AI-driven video content creation. Its platform uses artificial intelligence to generate dynamic videos from images, text, and audio, enabling businesses to produce scalable, personalized narratives cost-effectively without traditional video production teams.

BioCatch

Series C in 2020
BioCatch is a pioneering company specializing in behavioral biometrics, which focuses on analyzing the digital behavior of online users to enhance fraud detection and prevention. By leveraging advanced cognitive science and machine learning, BioCatch provides insights that help financial institutions identify potential risks associated with user interactions while maintaining privacy. The company's technology is designed to combat increasingly sophisticated fraud tactics, including social engineering scams, and to streamline the digital banking experience from account creation to login and beyond. With over a decade of experience and a robust portfolio of patents, BioCatch is committed to driving innovation in the field of digital security, enabling clients to effectively combat fraud while fostering a trusted online environment.

Revuze

Series A in 2020
Revuze is a pioneering company specializing in generative AI analysis for consumer insights derived from online reviews. They leverage large language model training to extract valuable insights from verified buyers across various e-commerce platforms. Revuze's cutting-edge solutions enable businesses to integrate review analytics into their marketing and product strategies, facilitating data-driven decision-making. The company offers real-time analysis with intuitive features, dynamic dashboards, and comprehensive reports, ensuring clients stay informed about their market categories' evolving landscape.

ConcertAI

Series B in 2020
ConcertAI is a Boston-based company established in 2018 that specializes in developing a suite of medical research tools focused on oncology. The company aims to enhance care-based oncology research and data analytics through its integrated real-world data and AI-driven solutions. ConcertAI’s offerings are designed to improve oncology health outcomes and clinical trial efficiency by utilizing custom patient surveys. This enables pharmaceutical companies to assess existing treatments and advance the development of new therapies. By facilitating the generation of real-world evidence and insights, ConcertAI assists project teams, medical experts, and scientists in delivering impactful research and innovations in cancer care.

Bounce

Series D in 2020
Bounce (formerly known as Metro Bikes) is a smart mobility solution, with a mission of making daily commute stress-free, time-saving, reliable, and convenient. With a breakthrough technology that lets users access the bike with just an OTP, the Keyless bikes, have not only done away with keys, but the whole process of renting a bike has just become devoid of any physical or human intervention. With Bounce's new One Way Rental service, users can now pick up and drop the bike anywhere they need to and be done with the ride. This is aimed at providing a seamless first mile and last-mile connectivity to metro users. Founded in 2014, Bounce aims at decongesting the roads by encouraging commuters to choose public transport by delivering convenient options to rent bikes and reach their destinations from metro stations. It is based in Bangalore, India.

Seer

Series D in 2019
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.

Infleqtion

Seed Round in 2019
Infleqtion, with offices in the United States, United Kingdom, and Australia, specializes in delivering advanced quantum information solutions tailored to meet critical market needs. Building on 17 years of pioneering research from ColdQuanta, the company develops software-configured, quantum-enabled products that enhance precision and processing power for applications in positioning, navigation, timing, global communication security, and efficiency. Infleqtion's technology serves various sectors, including commercial enterprises and governmental organizations, by providing high-value information streams that facilitate innovation in quantum matter. Its offerings encompass hardware products and AI-powered solutions aimed at advancing resilience in energy distribution and accelerating developments in quantum computing.

Remrise

Seed Round in 2019
Remrise, Inc. is a health and wellness company founded in 2018 and headquartered in San Francisco, California. The company specializes in personalized sleep aids that utilize drug-free, plant-based ingredients to enhance sleep quality. Customers begin their experience by taking a quiz that helps identify their specific sleep challenges, allowing Remrise to provide tailored sleep formulas. The key ingredients in these formulas include Reishi, Spine Date Seed, and L-Theanine. Additionally, Remrise offers a user-friendly application for tracking sleep patterns, helping individuals monitor their progress over time. The company focuses on integrating both Eastern and Western herbal traditions to support holistic health and improve overall well-being.

Bungalow

Series B in 2019
Bungalow is a residential real estate platform founded in 2016 by Andrew Collins and Justin McCarty, headquartered in San Francisco, California. The company focuses on providing convenient and flexible living solutions for renters, particularly early career professionals, by offering multi-bedroom homes in desirable neighborhoods across seven major U.S. cities. Bungalow signs long-term leases with homeowners and then furnishes these homes, providing private bedrooms and matching tenants with compatible housemates. Each furnished home includes amenities such as Wi-Fi, utilities, and housekeeping, along with monthly community events to foster social interaction among residents. This approach enables renters to enjoy high-quality living spaces while building a close-knit community.

HumanFirst

Seed Round in 2019
HumanFirst is a company focused on enhancing patient-centered clinical trials through its advanced precision measures platform, which is recognized as the world's largest AI-powered software-as-a-service solution for improving health outcomes. The platform offers insights and validated evidence data to support biopharmaceutical companies in their drug development processes, enabling them to incorporate digital health technologies, digital biomarkers, and electronic clinical outcome assessments. By providing industry educational tools and facilitating collaboration with research partners, HumanFirst helps biopharma organizations increase research efficiency and accelerate the deployment of innovative treatments. The platform has been utilized by a significant majority of the largest pharmaceutical companies globally, underscoring its role in transforming clinical research and driving the evolution of drug development.

Science Exchange

Debt Financing in 2019
Science Exchange, Inc. operates an online marketplace that facilitates collaboration between researchers and scientific service providers, including academic and government laboratories. Founded in 2011 and based in Palo Alto, California, the company enables users to search for, compare, and procure scientific services from U.S. research institutions, streamlining the process of obtaining quotes, managing projects, and processing payments. The platform enhances research and development productivity by automating various collaborative tasks while ensuring data security and regulatory compliance. By matching researchers seeking to outsource experiments with qualified service providers, Science Exchange makes it easier and more affordable for scientific institutions and researchers to access outsourced research and development services, ultimately accelerating the pace of scientific discovery.

Science Exchange

Venture Round in 2019
Science Exchange, Inc. operates an online marketplace that facilitates collaboration between researchers and scientific service providers, including academic and government laboratories. Founded in 2011 and based in Palo Alto, California, the company enables users to search for, compare, and procure scientific services from U.S. research institutions, streamlining the process of obtaining quotes, managing projects, and processing payments. The platform enhances research and development productivity by automating various collaborative tasks while ensuring data security and regulatory compliance. By matching researchers seeking to outsource experiments with qualified service providers, Science Exchange makes it easier and more affordable for scientific institutions and researchers to access outsourced research and development services, ultimately accelerating the pace of scientific discovery.

Mon Ami

Seed Round in 2019
Mon Ami is a platform-based company that serves both individuals and care providers for seniors. Its consumer-facing application connects college students with seniors and families to arrange companionship and support for conditions including dementia, Alzheimer’s, Parkinson’s, autism, and cancer. The company also offers a HIPAA-compliant software platform for aging and disability service providers that digitizes care delivery, streamlines operations, increases care capacity, and enables reporting on senior well-being. By partnering with agencies nationwide, Mon Ami aims to digitize frontline care and improve outcomes through a single integrated platform. The company was founded in 2018 and is based in Palo Alto, California, with operations across California.

Heap

Series C in 2019
Heap Inc. is a company that develops an analytics infrastructure designed for online businesses, enabling them to capture and analyze customer interactions across web, mobile, and cloud platforms. Founded in 2012 and headquartered in San Francisco, California, Heap's solution automates the collection and organization of customer behavioral data, such as clicks, transactions, and form submissions, without requiring additional coding. This streamlined approach allows businesses to gain a comprehensive understanding of their users, facilitating informed decision-making and enhancing product development. Heap serves a diverse range of industries, including e-commerce, financial services, and SaaS, with over 6,000 clients that include notable companies across various sectors. The company is committed to empowering organizations to focus on insights and actions that drive business success.

Seer

Series C in 2019
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.

1mg

Series D in 2019
1mg is an Indian digital healthcare platform, launched in 2015, that operates from Gurgaon, Haryana. It aims to make healthcare more accessible, understandable, and affordable. The platform enables users to find detailed information about prescribed medicines, buy them, and search for drugs based on ailments, classes, companies, and brands. Additionally, 1mg offers a doctor platform to help users find suitable healthcare professionals and a diagnostics service for transparent and cost-effective lab tests. The company empowers consumers and caregivers to choose the most appropriate healthcare services at competitive prices.

Aptible

Series A in 2019
Aptible Inc. is a technology company that provides a security management platform designed to automate HIPAA compliance for web and mobile developers, primarily serving digital health companies. Founded in 2013 and based in San Francisco, Aptible offers two main products: Aptible Enclave, a Docker-based platform that facilitates secure deployment into private AWS environments, and Aptible Gridiron, which assists cloud-based software engineering teams with security management. The company's platform as a service (PaaS) enables startups and scaling businesses to efficiently provision, manage, and scale their infrastructure, allowing developers to concentrate on product development rather than underlying complexities. Aptible's solutions incorporate essential enterprise requirements such as security, compliance, and reliability from the outset, ensuring that developers can build and grow their applications with ease.

Bounce

Series C in 2019
Bounce (formerly known as Metro Bikes) is a smart mobility solution, with a mission of making daily commute stress-free, time-saving, reliable, and convenient. With a breakthrough technology that lets users access the bike with just an OTP, the Keyless bikes, have not only done away with keys, but the whole process of renting a bike has just become devoid of any physical or human intervention. With Bounce's new One Way Rental service, users can now pick up and drop the bike anywhere they need to and be done with the ride. This is aimed at providing a seamless first mile and last-mile connectivity to metro users. Founded in 2014, Bounce aims at decongesting the roads by encouraging commuters to choose public transport by delivering convenient options to rent bikes and reach their destinations from metro stations. It is based in Bangalore, India.

Collective Health

Series E in 2019
Collective Health is a health benefits platform that integrates various medical, dental, vision, and pharmacy services into a cohesive solution aimed at simplifying healthcare for employees and their families. The company’s cloud-based platform streamlines the administration of health plans through a single portal, offering clear guidance, live concierge support, and digital tools for managing care. By reducing the administrative burden associated with health benefits, Collective Health enhances the member experience and aids organizations in controlling costs while improving health outcomes. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.